Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FITZROY: Filgotinib in Active Crohn's Disease
NCT02048618Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- Feb 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of filgotinib in Crohn's disease, sponsored by Galapagos NV. Started Feb 2014; status: completed.
02
Drugs
filgotinib
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02048618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02048618.